Mikov, Momir
Date issued
Fulltext
Results 1-13 of 13 (Search time: 0.005 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 1-Jan-2015 | An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulations | Mooranian A.; Negrulj R.; Mathavan S.; Martinez J.; Sciarretta J.; Chen-Tan N.; Mukkur T.; Momir Mikov ; Mladena Lalić-Popović ; Maja Stojančević; Svetlana Goločorbin-Kon ; Al-Salami H. |
| 2 | 1-Jan-2013 | Application of bile acids in drug formulation and delivery | Maja Stojančević; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 3 | 24-Oct-2019 | Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in Type 1 diabetes development in a murine mode | Armin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami |
| 4 | 26-Nov-2019 | Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model | Armin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević ; Hani Al-Salami |
| 5 | Dec-2019 | Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model | Armin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami |
| 6 | 8-Nov-2018 | Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 7 | 2-Oct-2017 | Bile acids and their oxo derivatives: environmentally safe materials for drug design and delivery | Jovana Trifunović; Vladan Borčić; Saša Vukmirović ; Velibor Vasović ; Momir Mikov |
| 8 | 1-May-2017 | Bile acids and their oxo derivatives: Potential inhibitors of carbonic anhydrase I and II, androgen receptor antagonists and CYP3A4 substrates | Jovana Trifunović; Vladan Borčić; Momir Mikov |
| 9 | 1-Jan-2008 | The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes | Momir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett |
| 10 | 28-Jul-2014 | Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study | Mooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Arfuso F.; Al-Salami H. |
| 11 | 17-Sep-2019 | Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants | Kecman, S; Škrbić R.; Alma Badnjević Čengić; Armin Mooranian; Hani Al-Salami; Momir Mikov ; Svetlana Goločorbin-Kon |
| 12 | 1-Jan-2019 | Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice | Mooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H. |
| 13 | 2019 | Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Saša Vukmirović ; Jelena Lazić; Hani Al-Salami; Momir Mikov |